We have previously shown that VegT mRNA plays a structural (translation-independent) role in the organization of the cytokeratin cytoskeleton in Xenopus oocytes. The depletion of VegT mRNA causes the fragmentation of the cytokeratin network in the vegetal cortex of Xenopus oocytes. This effect can be rescued by the injection of synthetic VegT RNA into the oocyte. Here, we show that the structural function of VegT mRNA in Xenopus oocyte depends on its combinatory signals for the induction or facilitation and for the maintenance of the depolymerization vs. polymerization status of cytokeratin filaments and that the 300-nucleotide fragment of VegT RNA isolated from the context of the entire molecule induces and maintains the depolymerization of cytokeratin filaments when injected into Xenopus oocytes. A computational analysis of three homologous Xenopus VegT mRNAs has revealed the presence, within this 300-nucleotide region, of a conserved base-pairing (hairpin) configuration that might function in RNA/protein interactions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00441-011-1255-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of new head and neck squamous cell carcinoma molecular imaging targets.
Oral Oncol
April 2024
Department of Otorhinolaryngology, Head and Neck Surgery, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands. Electronic address:
Objectives: Intraoperative fluorescence imaging (FI) of head and neck squamous cell carcinoma (HNSCC) is performed to identify tumour-positive surgical margins, currently using epidermal growth factor receptor (EGFR) as imaging target. EGFR, not exclusively present in HNSCC, may result in non-specific tracer accumulation in normal tissues. We aimed to identify new potential HNSCC FI targets.
View Article and Find Full Text PDFFourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
EClinicalMedicine
July 2023
Department of Haematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, Netherlands.
Background: Patients with haematological malignancies have impaired antibody responses to SARS-CoV-2 vaccination. We aimed to investigate whether a fourth mRNA COVID-19 vaccination improved antibody quantity and quality.
Methods: In this cohort study, conducted at 5 sites in the Netherlands, we compared antibody concentrations 28 days after 4 mRNA vaccinations (3-dose primary series plus 1 booster vaccination) in SARS-CoV-2 naive, immunocompromised patients with haematological malignancies to those obtained by age-matched, healthy individuals who had received the standard primary 2-dose mRNA vaccination schedule followed by a first booster mRNA vaccination.
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
J Exp Clin Cancer Res
June 2023
Department of Medical Oncology, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands.
Background: Hypoxia-induced glycogen turnover is implicated in cancer proliferation and therapy resistance. Triple-negative breast cancers (TNBCs), characterized by a hypoxic tumor microenvironment, respond poorly to therapy. We studied the expression of glycogen synthase 1 (GYS1), the key regulator of glycogenesis, and other glycogen-related enzymes in primary tumors of patients with breast cancer and evaluated the impact of GYS1 downregulation in preclinical models.
View Article and Find Full Text PDFAntibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
JAMA Oncol
October 2022
Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
Article Synopsis
- A third dose of the mRNA-1273 COVID-19 vaccine is commonly given to immunocompromised patients with hematologic cancers, though there is limited data to support its effectiveness.
- The study assessed whether this third dose increases antibody levels in these patients to levels comparable to healthy individuals who receive the standard two doses.
- Results showed that the third dose significantly raised antibody concentrations, especially in patients with recovering immune systems, with those who had myeloid cancers or were recipients of certain transplants achieving similar antibody levels to healthy individuals.
An mRNA expression-based signature for oncogene-induced replication-stress.
Oncogene
February 2022
Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
Oncogene-induced replication stress characterizes many aggressive cancers. Several treatments are being developed that target replication stress, however, identification of tumors with high levels of replication stress remains challenging. We describe a gene expression signature of oncogene-induced replication stress.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!